U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
154561154561OraTest in Combination With Visual Examination and Visual Examination AloneTerminatedHas ResultsHead and Neck Cancer|Oropharynx CancerOther: Visual Examination|Drug: OraTesthttps://ClinicalTrials.gov/show/NCT00537199
154562154562A Study of Iron Oligosaccharide in CHF PatientsCompletedNo Results AvailableHeart Failure, CongestiveDrug: Iron oligosaccharidehttps://ClinicalTrials.gov/show/NCT00537186
154563154563Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast CancerTerminatedNo Results AvailableBreast CancerProcedure: Core Biopsy|Procedure: Blood Collection|Drug: Paclitaxel|Drug: Avastinhttps://ClinicalTrials.gov/show/NCT00537173
154564154564Diet and Exercise in Overweight Children PostburnWithdrawnNo Results AvailableObesity|BurnsBehavioral: Behavior modification, Nutrition Education, Exercisehttps://ClinicalTrials.gov/show/NCT00537160
154565154565Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy AdultsCompletedNo Results AvailableWest Nile FeverBiological: WN/DEN4delta30 vaccine|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00537147
154566154566Trial on Endovascular Aneurysm ManagementSuspendedNo Results AvailableBrain AneurysmDevice: Embolization, coiling|Other: Conservative managementhttps://ClinicalTrials.gov/show/NCT00537134
154567154567Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNo Results AvailableEsophageal Cancer|Gastric Cancer|Liver CancerDrug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: vorinostat|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00537121
154568154568Community-Based Care Management For Teen/Young Adult Mothers and FathersCompletedNo Results AvailablePregnancyBehavioral: Home visiting and care managementhttps://ClinicalTrials.gov/show/NCT00537108
154569154569Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerCompletedHas ResultsThyroid NeoplasmsDrug: Vandetanib|Other: Placebohttps://ClinicalTrials.gov/show/NCT00537095
154570154570Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS)CompletedHas ResultsMultiple SclerosisDrug: FTY720|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00537082
154571154571Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRICompletedNo Results AvailableKidney Neoplasms|Carcinoma, Renal Cell|Kidney (Renal Cell) CancerProcedure: FDG PET CT|Procedure: DCE MRI|Drug: F-18 Fluoro-deoxi-glucose|Drug: Gadolinium-DTPA|Drug: Sunitinibhttps://ClinicalTrials.gov/show/NCT00537056
154572154572A Study to Compare COREG CR to COREG CR Fixed-dose Combination in Patients With High Blood PressureCompletedNo Results AvailableHypertensionDrug: SK&F-105517 (COREG CR FDC)https://ClinicalTrials.gov/show/NCT00537043
154573154573Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic LeukemiaActive, not recruitingHas ResultsAdult Acute Lymphoblastic Leukemia|Childhood Acute Lymphoblastic LeukemiaOther: laboratory biomarker analysis|Other: pharmacological study|Drug: asparaginasehttps://ClinicalTrials.gov/show/NCT00537030
154574154574Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)CompletedNo Results AvailableParkinson Disease|Neurodegenerative Diseases|Central Nervous System Diseases|Movement Disorders|Brain DiseasesDrug: SCH 420814https://ClinicalTrials.gov/show/NCT00537017
154575154575Language in Primary Progressive AphasiaRecruitingNo Results AvailablePrimary Progressive Aphasiahttps://ClinicalTrials.gov/show/NCT00537004
154576154576Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate CancerActive, not recruitingNo Results AvailableProstate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage III Prostate Cancer|Stage IV Prostate CancerDietary Supplement: Calcitriol|Drug: Ketoconazole|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Therapeutic Hydrocortisonehttps://ClinicalTrials.gov/show/NCT00536991
154577154577Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid MalignanciesCompletedHas ResultsLymphoma|LeukemiaDrug: ARA-C|Drug: BCNU|Drug: Campath-1H|Drug: Cyclophosphamide|Drug: Etoposide|Drug: Fludarabine|Drug: Melphalan|Drug: Rituximab|Other: Allogeneic Stem Cell Transplantation|Radiation: Total body radiation (TBI)|Drug: Methotrexate|Drug: Tacrolimus|Procedure: Adback NK or T Cellhttps://ClinicalTrials.gov/show/NCT00536978
154578154578Percentage of Secondary Prevention Patients Treated to Their LDL-C TargetsCompletedNo Results AvailableHyperlipidemias|Atherosclerosis|Coronary Heart Disease|Carotid Stenosis|Peripheral Vascular Diseases|Diabetes Mellitushttps://ClinicalTrials.gov/show/NCT00536965
154579154579Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + ChemotherapyActive, not recruitingNo Results AvailableHead and Neck CancerDrug: Pulmozyme|Drug: Placebo|Radiation: Radiation Therapyhttps://ClinicalTrials.gov/show/NCT00536952
154580154580Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast CancerCompletedNo Results AvailableBreast CancerDrug: enzastaurin|Drug: bevacizumab|Drug: paclitaxel|Drug: placebohttps://ClinicalTrials.gov/show/NCT00536939
154581154581Telecommunication Via Cell Phones During Post-Operative Treatment After Lung TransplantationCompletedNo Results AvailableLung TransplantationDevice: Home spirometry with data transfer via cell phone|Device: Home spirometer with BT-cellphone|Device: Home spirometer w/o BThttps://ClinicalTrials.gov/show/NCT00536926
154582154582Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With AsthmaCompletedHas ResultsAsthmaDrug: Budesonide/formoterol pMDI 40/2.25ug + spacer|Drug: Budesonide/formoterol pMDI 40/2.25 ughttps://ClinicalTrials.gov/show/NCT00536913
154583154583Clinical Trial of Abstinence-Linked Money ManagementCompletedNo Results AvailableSubstance AbuseBehavioral: Advisor-Teller Money Manager|Behavioral: FIThttps://ClinicalTrials.gov/show/NCT00536900
154584154584Effects of Atorvastatin 10 mg Versus 40 mg in Eight Months Follow-up Coronary Flow Reserve and Bone Marrow Stem Cell Mobilization in Patients With Acute Myocardial InfarctionCompletedNo Results AvailableAcute Myocardial InfarctionDrug: atorvastatinhttps://ClinicalTrials.gov/show/NCT00536887
154585154585Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryActive, not recruitingNo Results AvailablePancreatic CancerDrug: gemcitabine hydrochloride|Drug: oxaliplatin|Genetic: protein expression analysis|Genetic: proteomic profiling|Other: diagnostic laboratory biomarker analysis|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgeryhttps://ClinicalTrials.gov/show/NCT00536874
154586154586Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung Cancer|Brain MetastasesDrug: erlotinibhttps://ClinicalTrials.gov/show/NCT00536861
154587154587The Effect of Probiotics on the Immune Status, Diarrhea and Bacterial Vaginosis Cure Rate Among HIV PatientsActive, not recruitingNo Results AvailableHIV Infections|Diarrhea|Bacterial VaginosisDietary Supplement: Lactobacillus rhamnosus GR-1 + Lactobacillus reuteri RC-14|Dietary Supplement: Placebo|Drug: Metronidazolehttps://ClinicalTrials.gov/show/NCT00536848
154588154588Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins LymphomaCompletedNo Results AvailableAdvanced Solid Tumor|Lymphoma, Non-Hodgkin|Non-Hodgkin's LymphomaDrug: GSK461364https://ClinicalTrials.gov/show/NCT00536835
154589154589Antioxidant Status During Burn RehabilitationWithdrawnNo Results AvailableBurnshttps://ClinicalTrials.gov/show/NCT00536822
154590154590Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal CancerCompletedHas ResultsMetastatic Colorectal Cancer|Responsive to Fluoropyrimidines|Advanced Colorectal Cancer|Neoplasms, ColorectalDrug: lapatinib|Drug: oxaliplatin|Drug: capecitabinehttps://ClinicalTrials.gov/show/NCT00536809

* Görseller ve İçerik tekif hakkına sahip olabilir